Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Kerry Mitchell

Psychosomatic Medicine San Francisco, CA Medical Doctor

NPI 1104043975 CMS profile 49676

2485 Clay Street, Suite 104, San Francisco, CA 94115

Open in the dashboard

General payments

$1,419

60 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Kerry Mitchell of San Francisco, CA is reported in the CMS Open Payments database as having received $1,419 across 60 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Psychosomatic Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $362 12
2020 General $255 9
2019 General $802 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kerry Mitchell
  • Psychosomatic Medicine median
  • Middle half of Psychosomatic Medicine
  • National median

In program year 2025, general payments to Kerry Mitchell were reported at $0. Among 72 Psychosomatic Medicine profiles paid that year, the median was $152 and the middle half received between $47 and $428.

Show as a table
Year Kerry Mitchell Psychosomatic Medicine median Middle half National median
2019 $802 $125 $51–$524 $163
2020 $255 $117 $29–$251 $114
2021 $362 $123 $33–$366 $132
2022 $0 $107 $37–$450 $149
2023 $0 $131 $57–$397 $160
2024 $0 $122 $27–$293 $164
2025 $0 $152 $47–$428 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Allergan Inc. $471 22 payments
  2. Otsuka America Pharmaceutical, Inc. $438 14 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $314 15 payments
  4. Lundbeck LLC $150 6 payments
  5. AbbVie, Inc. $23 2 payments
  6. Jazz Pharmaceuticals Inc. $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Food and Beverage $1,419 60 payments
Products named General payments · program years 2019–2021
  1. VRAYLAR Neuroscience $471 22 payments
  2. REXULTI Psychiatry $438 14 payments
  3. Trintellix Central Nervous System (CNS) $179 9 payments
  4. REXULTI Psychiatry $150 6 payments
  5. TRINTELLIX Neuroscience $135 6 payments
  6. VRAYLAR Neuroscience $23 2 payments
  7. SUNOSI $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

60 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychosomatic Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record